Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid

NCT03092765 PHASE2 TERMINATED

This study is a placebo-controlled, randomized, double-blind, multicenter, parallel-group comparison study in primary biliary cholangitis participants inadequately responding to ursodeoxycholic acid.

Details

Lead sponsor	EA Pharma Co., Ltd.
Phase	PHASE2
Status	TERMINATED
Enrolment	29
Start date	Mon May 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Oct 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Primary Biliary Cholangitis

Interventions

• E6011
• Placebo

Countries

Japan